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Abstract 
Background: Greater research utilisation in cancer nursing practice is needed in Australia in 
order to provide well-informed and effective nursing care to people affected by cancer. This 
paper aims to report on the implementation of evidence-based practice in a tertiary cancer 
care centre. Methods: Using a case report design, this paper reports on the use of the 
Collaborative Model for Evidence Based Practice in an Australian tertiary cancer care centre. 
The clinical case is the uptake of routine application of chlorhexidine-impregnated sponge 
dressings for preventing centrally inserted catheter-related bloodstream infections – a 
common problem in people with cancer. In this case report, a number of processes that 
resulted in a service-wide practice change are described.  Results: This model was 
considered a feasible method for successful research utilisation. In this case report, the 
chlorhexidine-impregnated sponge dressings were introduced in the tertiary cancer care 
centre with an aim of reducing the incidence of centrally inserted catheter-related 
bloodstream infections and potentially improving patient health outcomes.  
Conclusion: The collaborative model is feasible and effective for implementing clinical 
evidence into cancer nursing practice. The successful implementation of evidence-based 
practice in cancer care centres requires cancer nurses and health administrators to ensure a 
supportive infrastructure and environment for clinical inquiry and research utilisation 
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Background 
The World Health Organization (WHO, 2009) predicts 15.5 million people will be diagnosed 
with cancer worldwide in 2030, compared with 11.3 million in 2007.(1) The growing number 
of people being diagnosed has a tremendous effect on the demand for cancer care services, 
presenting a number of challenges for cancer nurses in relation to their workload, nurse-
patient ratio and the need to provide cost-effective and quality nursing care (2, 3). It is vital 
that cancer nurses continue to support and contribute to improving patient care and nursing 
practice, despite these challenges.(2, 3). 
 
Cancer nursing is a dynamic entity, which inevitably undergoes change due to technological 
and scientific advances, as well as an evolving nursing profession (2, 4) . A new generation 
of nurse innovators, leaders and researchers is required to ensure that evidence is utilised in 
clinical practice to justify changes to patient care (5, 6). Current literature emphasises the 
need for all cancer care nurses to deliver evidence-based nursing care, through clinical 
inquiry, continual research utilisation and implementation (2, 5). However, several barriers 
exist when implementing nursing research into practice, leading to insufficient research 
utilisation within the clinical setting (2, 3, 5, 7). Even when evidence is used, there has been a 
concern about the lag time from evidence generation to evidence utilisation in practice (7, 8). 
 
A number of challenges prevent cancer nurses from being engaged in primary research and 
evidence utilisation in patient care (2, 3). These challenges include being too busy with 
clinical care to actively participate in research, having insufficient research skills, lack of 
interest in research, and limited time and resources (2, 3). At an organisational level, a lack of 
effective interventions to overcome the existing barriers inhibits nursing science from being 
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used in practice (5, 7, 9). A Cochrane systematic review conducted by Foxcroft and Cole 
(2009) attempted to identify effective organisational infrastructure that supported an increase 
in the utilisation of research in nursing practice (10) . However, they found no studies that 
provided rigorous enough data to be recommended as an effective nursing research utilisation 
strategy (10). 
 
A number of frameworks facilitated the process for implementing evidence-based practice in 
clinical decision making and care (11-13). Each of these frameworks describes the steps 
required to utilise research in practice and consequently improve patient outcomes (11-
13).When practice is underpinned by evidence-based policies and procedures, patient 
outcomes should subsequently be improved (13). However, it is unclear how these 
frameworks could be applied in the area of cancer nursing (13). 
 
Methods 
This paper uses a case report design to describe the steps involved in implementing an 
evidence-based framework for clinical decision making at a service level. This paper also 
presents the results of a systematic review investigating the effects of routine use of 
chlorhexidine-impregnated sponge dressings in reducing centrally inserted catheter-related 
bloodstream infections. Chlorhexidine-impregnated sponge dressings are small disk shaped 
sponges saturated with chlorhexidine gluconate that is released for 7 days. These dressings fit 
around the central venous access devices (CVAD) at the entry site and are then covered with 
traditional transparent polyurethane dressings to hold them in place. This case report 
describes a number of processes that resulted in a service-wide practice change in an 
Australian tertiary cancer care centre in 2009. The systematic review presented in this paper 
is an original work and has not been published elsewhere. 
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Clinical Setting  
The setting is a cancer care centre of an Australian tertiary referral hospital. Each day the 
centre serves approximately 68 in-patients, 200 radiation therapy outpatients, 200 patients 
attending specialised cancer care clinics and 90 patients attending the day therapy unit. In 
2009, there were more than 130,000 occasions of service within the centre. Two hundred and 
seventy full-time registered nurses provide nursing services in the centre to the departments 
of haematology, bone marrow transplant, medical oncology, radiation oncology and the 
haemophilia centre. Specialist nursing services in the team included ten Clinical Nurse 
Consultants, one Nurse Researcher, and two Nurse Educators. 
 
Theoretical Model 
An evidence-based practice framework is one way to guide the implementation of research 
into nursing practice by providing appropriate steps to improve patient outcomes(5, 7). The 
Collaborative Model was selected to guide the current case report. The model was  first 
described by Caramanica and colleagues (insert endnote citation) as a result of the 
collaboration of nine hospitals and educational organisations, with the aim of enabling 
effective nursing research utilisation(5). Specifically, the authors described the crucial steps 
one might take from the research appraisal phase to ultimately revising clinical pathways and 
changing clinical practice (5).  
This research utilisation model includes several steps such as: 
o identifying the clinical problem  
o clarification of the problem  
o performing research appraisal  
o determining alternative solutions  
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o examining implications for clinical practice and testing/implementing practice 
change; revising current clinical pathways (based on results of trial and current 
research), and delivering evidence-based practice  
 
INSERT FIGURE 1 
 
Case report: A service-wide uptake of chlorhexidine-impregnated sponge 
dressings in an Australian tertiary cancer care centre  
1. Problem identification and clarification 
Central venous access devices (CVADs) are widely used internationally in oncology and 
haematology settings. Whilst they are an extremely effective method of delivering 
intravenous therapy, they also pose a risk of infection, especially to cancer patients who are 
already immuno-compromised. Catheter-related bloodstream infections can be life-
threatening and very debilitating for patients, often requiring prolonged hospitalisation 
alongside increased costs for the healthcare provider(14-16). Colonisation by skin flora and 
other organisms around the central catheter insertion site is strongly associated with an 
increased risk of developing catheter-related bloodstream infections(17). It has been 
estimated that in the United States each infection has a mean attributable cost of US$18,000 
and a prolonged hospital stay of 12 days per episode(14), emphasizing the necessity of 
evaluating any potentially effective method of reducing the risk of developing an infection. 
 
The Nurse Unit Manager (NUM) at the day therapy unit of the cancer care centre was 
responsible for purchasing equipment for the operations of the unit. At first, the NUM was 
approached by sales representatives with promotional materials, who claimed that current 
clinical evidence supported the routine use of the dressings in order to reduce infection rates.  
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The standard CVAD dressing in use in the institution at that time was gauze and tape type 
dressings, applied at the time of insertion and then replaced at 24 hours with a transparent 
polyurethane dressing.  The polyurethane dressing was replaced every 7 days, at any time the 
dressing was soiled, loose, or had visible blood pooled under it. Both dressings are 
recommended under various clinical practice guidelines (18, 19) . 
 
Whilst the NUM agreed that catheter-related blood stream infections are a valid clinical 
problem in cancer care, she was unsure whether the claims and data provided by the sale 
representatives were accurate. Thus a systematic review of the current clinical evidence on 
the effectiveness of chlorhexidine-impregnated sponge dressings to reduce catheter-related 
blood stream infections was warranted, prior to trialling this product in the unit. At this stage, 
the NUM and the Nurse Researcher proposed relevant clinical questions to resolve the 
identified clinical problem. The Nurse Researcher is co-located in the clinical environment of 
the cancer care centre (2). The clinical questions were; is the routine use of chlorhexidine-
impregnated sponge dressings justified for reducing catheter-related blood stream infections 
in cancer patients with CVADs in our cancer care centre?; andare the dressings more 
effective in reducing infections than the products used in current practice guidelines for 
CVAD dressing changes? The Nursing Director was informed of the initiation and the 
progress of the project throughout the project life. 
 
2. Research appraisal: conducting a systematic review  
After the clinical problem had been identified and clarified, the Nurse Researcher conducted 
a literature search during 2009 locating a systematic review conducted by Ho and colleagues 
in 2005  (20). The use of systematic reviews has been well recognised in health care to 
inform clinical decisions (21). The meta-analysis conducted by Ho was published in 2006 and 
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reported results that favoured the use of chlorhexidine-impregnated sponge dressings in a 
mixed population of neonates and adults with epidural catheters or centrally inserted catheters 
(20). This systematic review searched for trials up to November 2005, four years prior to the 
current review. Thus, an updated review, limiting the population to adult patients receiving 
cancer care and intensive care was needed to further validate the use of the dressings in this 
clinical setting. Limiting the population to adult patients in the current review was expected 
to provide more precise and clinically applicable data for the decision making in this instance. 
It is expected that this updated review would provide a greater precision for number-needed-
to-treat analysis and be a useful clinical tool to guide and inform practice in this cancer care 
centre. 
 
While it was expected that this clinical case has practice implication for all units in the cancer 
care centre, in applying the collaborative model for practice development at the service level, 
it was decided that the day therapy unit would be responsible for research appraisal for this 
clinical case. After negotiations between the Nurse Researcher and the NUM, a registered 
nurse (RN) from the day therapy unit was released from a direct clinical service provision 
role for twelve days to conduct an updated systematic review with the Nurse Researcher. The 
systematic review aimed to report on the results of available evidence up to September 2009, 
specifically focusing on adults with CVADs. The primary objective of this review was to 
compare the number of catheter-related blood stream infections occurring in adult patients in 
whom chlorhexidine-impregnated sponge dressings were used, against the number of 
infections occurring in patients in whom the dressings were not used, to evaluate the 
effectiveness of the dressings in reducing infections and catheter colonisation.  
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The standard methodology of the Cochrane Collaboration was used. A search was undertaken 
of the Cochrane Central Register of Controlled Trials (Issue 4, 2009), Medline, EMBASE 
and CINAHL for relevant articles. All databases were searched during September 2009, using 
the following MeSH terms : antimicrobial, antimicrobial dressing, Biopatch®, Broviac®, 
catheter, catheterisation, dressing, central venous, central, chlorhexidine, chlorhexidine 
gluconate-impregnated, chlorhexidine impregnated, Hickman® line and venous. Hand 
searching of infection, disease and cancer care journals, as well as relevant conference 
proceedings was performed. No language or date of publication restrictions were employed 
during this search. Reference lists of all retrieved articles were searched for additional 
studies.  
 
The RN and the Nurse Researcher reviewed each paper independently. Randomised 
controlled trials in which the effect of chlorhexidine-impregnated sponge dressings could be 
compared with a control group which received no chlorhexidine-impregnated sponge 
dressings were considered. Participants in the included studies were adult patients (> 18 
years) with a CVAD and a chlorhexidine-impregnated sponge dressing. There were no 
restrictions placed on the diagnosis of the patient or setting (e.g. in-patient, outpatient) when 
conducting this search. This systematic review included five randomised controlled trials  
involving up to 2993 patients in cancer care and critical care units (22-26). This review 
identified an additional trial that was not included in Ho’s 2006 review (20) involving an 
additional 3778 adult patients. All included published studies investigated the effects of 
Biopatch®, but not any other brand or type of chlorhexidine based dressings. Two meta-
analyses were performed using the results of the five included studies (22-26). The results 
strongly favoured the use of chlorhexidine-impregnated sponge dressings on central catheter 
entry sites for reducing catheter-related blood stream infections (Odd Ratio [OR]: 0.43, 95%; 
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Confidence Interval [CI]: 0.29, 0.64) and catheter colonisation (OR: 0.43, 95% CI: 0.36, 
0.51).  
 
The forest plots evaluated the use of the dressings versus the use of non-chlorhexidine-
impregnated sponge dressings, and compared and contrasted the incidence of catheter-related 
blood stream infections and catheter colonisation between these two groups (shown in figures 
2 and 3 respectively). Despite the methodological differences across the included studies, 
heterogeneity I2 of the meta-analysis using catheter-related blood stream infections as the 
main outcome was 0%. Although heterogeneity I2 was higher for catheter colonisation (32%), 
it could be considered as being insignificant.(27) The insignificant heterogeneity indicated 
the pooling of day between these trials were appropriate. The number-needed-to-treat 
analysis for preventing catheter-related blood stream infections was 62; that is one episode of 
infection can be prevented in every 62 patients when the chlorhexidine-impregnated sponge 
dressings are routinely used. One episode of catheter colonisation can be prevented in every 
11 patients with the use of the dressing.  
 
INSERT FIGURE 2 
INSERT FIGURE 3 
 
3. Determining alternative solutions: the implications for clinical practice 
The Nurse Researcher and the NUM discussed the findings of the systematic review and the 
subsequent implications for clinical practice. The meta-analysis presented in this review 
reported results favouring the routine use of chlorhexidine-impregnated sponge dressings on 
CVADs (22). This review intended to examine whether chlorhexidine-impregnated sponge 
dressings should be routinely used in the cancer care centre. In addition to considering the 
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evidence, a cost analysis was performed. Each dressing costs AUD$6.25 and should be 
changed 24 hours after line insertion and every seven days thereafter, as per local policy and 
manufacturer recommendations. According to a local database, the median length of time that 
CVADs were in-situ in cancer patients was 29 days. Therefore, if a central catheter is in-situ 
for 29 days, it will require six dressings during this time. Therefore, the cost of preventing 
one episode of catheter-related blood stream infection is AUD$2325. That is, AUD$6.25 
(dressing cost) x 6 (number of dressings required over 29 days) x 62 (number needed to treat) 
= AUD$2325.  
 
Although this may initially seem a significant cost, one report in 2007 suggested that the 
economic implications of treating a catheter-related blood stream infection are far greater 
(14). Halton et al describe an episode of catheter-related blood stream infection leading to an 
increase of USD$18,000 in hospital costs and a 12-day increase in hospital length of stay, 
notwithstanding the increased morbidity and mortality risks to the patient (14). Unfortunately, 
Australian data on catheter-related blood stream infection were not available for comparison 
at the time of the project. In addition, nursing time associated with the use of such dressings 
was expected to be minimal. In summary, this review concluded that chlorhexidine-
impregnated sponge dressings provide a simple, cost-effective method to reduce the 
incidence of catheter-related blood stream infections occurring in patients within the cancer 
care centre. 
 
4. Testing/ implementing practice change 
Upon completing the cost analysis, systematic review and subsequent educational meetings, 
the Nurse Researcher and the NUM of the day therapy unit presented the findings to the 
Nursing Director of Cancer Care Services, who held the ultimate fiscal responsibility over all 
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the units within the cancer care centre. The Nursing Director has since approved the use of 
the dressings throughout the service and it is now standard practice to apply the dressings, 
covered by a non-occlusive dressing, when changing CVAD dressings at this hospital. In this 
case report, the support of the Nursing Director was identified as a crucial factor to the 
successful roll-out of the practice. 
 
Subsequently, the Nurse Researcher disseminated the results of the systematic review using 
posters and clinical education meetings. In these education meetings, the results of the cost 
analysis and systematic review on chlorhexidine-impregnated sponge dressings were 
presented to all registered nurses in the cancer care centre. The manufacturer’s representative 
was also invited to teach the nurses about the correct application of these dressings. All 
nurses were asked if they had any objections to the proposed change in practice. No nurses 
expressed objections to using the dressings for CVADs in the cancer care centre.  
 
 
Discussion 
The systematic review in this case report conveyed chlorhexidine-impregnated sponge 
dressings as a cost-effective and simple clinical intervention to reduce the incidence of 
catheter-related blood stream infections in adult patients within cancer care services. 
However, this case report also identified the challenges encountered by nurse administrators 
and clinical nurses in making evidence-based decisions. These challenges echoed the barriers 
as reported by the literature. Although a number of frameworks are now available to facilitate 
evidence-based practice, this case report demonstrated a feasible operationalisation of a 
collaborative model.  
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The collaboration between the Nurse Researcher, the nurse administrators and the clinical 
nurses was the key to the success of this clinical case. The Nursing Director’s awareness of 
the initiation and progress of the project was important, as she was able to champion for any 
research, practice change and budgetary efficiencies. It is crucial for cancer care services and 
health administrators to allocate sufficient resources to provide appropriate infrastructure to 
enable evidence generation and research utilisation at the service level. For cancer care 
centres that have no access to a Nurse Researcher, formal links with University academics 
can be formed (e.g. joint appointments/ research fellows).    
 
This case report followed the collaborative model, which described four important steps:  
1. problem identification and clarification 
2. literature search and research appraisal  
3. determining the alternative solutions and implications for clinical practice, and  
4. testing/implementing practice change.  
It is also important to acknowledge that there were a number of randomised controlled trials 
available in the literature for meta-analysis in this case report. In cases whereby high level of 
evidence does not exist, it would be prudent to await evidence for primary research prior to 
practice change.  
 
The scope of this paper is limited to the report of an evidence-based practice process, but did 
not further evaluate the effects of the practice change in terms of clinical outcomes. However, 
this case report outlines the essential steps for evidence-based practice and provides the 
rationale and estimated analysis of cost-effectiveness to justify the practice change. It is also 
acknowledged that, in an ideal situation, the systematic review conducted in the evidence-
based practice process should be peer-reviewed. The quality of the systematic review in this 
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case report was upheld by adhering to the methodology of the Cochrane Collaboration for 
systematic review.  
 
Conclusion 
A collaborative model for research utilisation in cancer nursing is feasible to inform the 
practice of cancer nurses and ensure effective patient care is delivered, subsequently 
improving healthcare outcomes. A supportive infrastructure and environment for clinical 
inquiry and research utilisation has been identified as necessity to enable successful 
implementation of evidence-based practice.  
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Figure 1. The Collaborative Model for Evidence Based Practice (adapted with permission)(5) 
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Figure 2. The forest plot comparing the use of chlorhexidine-impregnated sponge dressings 
versus not using chlorhexidine-impregnated sponge dressings in catheter related 
bloodstream infections 
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Figure 3. The forest plot comparing the use of chlorhexidine-impregnated sponge dressings 
versus not using chlorhexidine-impregnated sponge dressings in catheter colonisation 
 
 
 
 
 
 
 
 
 
